CK-Exogene Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
10
- Latest Deal Type
-
Out of Business
CK-Exogene General Information
Description
Operator of a bio-venture company intended to offer drugs for various diseases. The company provides treatments for diseases like corona, arthritis and AIDS by dramatically improving the scarcity of exosome extraction from cells, providing clients with drugs from extensive stem cell research.
Contact Information
Website
www.ckexogene.comCorporate Office
- 10, Gwangnaru-ro 8-gil
- Seoul, Seongdong-gu
- South Korea
Corporate Office
- 10, Gwangnaru-ro 8-gil
- Seoul, Seongdong-gu
- South Korea
CK-Exogene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 26-Jun-2024 | Completed | Out of Business | |||
| 1. Seed Round | 01-Jan-2022 | Completed | Generating Revenue |
CK-Exogene Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CK-Exogene Patents
CK-Exogene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025063339-A1 | Exosomes comprising cartilage homeostasis factor and composition comprising same for regenerating skin or cartilage | Inactive | 20-Sep-2023 | ||
| WO-2023085821-A1 | Exosome-based antiviral vaccine and manufacturing method thereof | Inactive | 10-Nov-2021 | ||
| WO-2023075557-A1 | Exosome containing cartilage homeostasis factors, and composition for preventing or treating osteoarthritis including same | Inactive | 29-Oct-2021 | ||
| WO-2022231116-A1 | Exosome platform-based antiviral vaccine | Inactive | 27-Apr-2021 | ||
| EP-3943597-A1 | Method for preparation of mesenchymal stem cell-derived exosome and cell culture prepared therefrom | Active | 25-May-2020 | C12N5/0667 |
CK-Exogene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CK-Exogene FAQs
-
When was CK-Exogene founded?
CK-Exogene was founded in 2019.
-
Where is CK-Exogene headquartered?
CK-Exogene is headquartered in Seoul, South Korea.
-
What is the size of CK-Exogene?
CK-Exogene has 10 total employees.
-
What industry is CK-Exogene in?
CK-Exogene’s primary industry is Drug Delivery.
-
Is CK-Exogene a private or public company?
CK-Exogene is a Private company.
-
What is CK-Exogene’s current revenue?
The current revenue for CK-Exogene is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
